Recon: Japan Clears $306k Pricetag for Novartis’ Kymriah – Regulatory Focus
Recon: Japan Clears $306k Pricetag for Novartis’ Kymriah Regulatory Focus
Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing. In Focus: US. Vertex to pay startup Kymera $70 million in R&D …
